Author Correction: Obesity induces PD-1 on macrophages to suppress anti-tumour immunity
Jackie E. Bader(Vanderbilt University Medical Center), Jeffrey C. Rathmell(University of Chicago), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Matthew Z. Madden(Emory University), Emily N. Arner(Vanderbilt University Medical Center), Cynthia A. Reinhart‐King(Rice University), Emma S. Hathaway(Vanderbilt University Medical Center), Madelyn D. Landis(University of Pennsylvania), Laura V. Pinheiro(Cancer Research Institute of the Slovak Academy of Sciences), Bradley I. Reinfeld(Vanderbilt University Medical Center), Matthew A. Cottam(Vanderbilt University), Wenjun Wang(Vanderbilt University), Kyra Smart(Vanderbilt University), Madison E. Bates(Vanderbilt University), KayLee K. Steiner(Vanderbilt University Medical Center), Kathryn E. Beckermann(Vanderbilt University Medical Center), Gabriel A. Needle(Vanderbilt University Medical Center), Amondrea Blackman(Vanderbilt University Medical Center), W. Kimryn Rathmell(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Alyssa H. Hasty(Vanderbilt University), Christa Aubrey(University of Alberta), Melissa M. Wolf(Vanderbilt University), Anthos Christofides(Beth Israel Deaconess Medical Center), Eden E Faneuff(Vanderbilt University Medical Center), Zaid Hatem(Vanderbilt University Medical Center), Xiang Ye(Qilu Hospital of Shandong University), DuPreez Smith(University of Alberta), Cheng‐Han Lee(University of Alberta), Heidi Chen(Vanderbilt University Medical Center), Gian Luca Lupica-Tondo(Vanderbilt University Medical Center), C. Henrique Serezani(Vanderbilt University), Kathryn E. Wellen(Cancer Research Institute), Scott M. Haake(Vanderbilt University Medical Center)
Cited by 2
Related Papers
Inflammation, stress, and diabetes
|Journal of Clinical Investigation|2005|3.9k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
|The Journal of Immunology|2011|2k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k